Zibotentan and Dapagliflozin Combination, EvAluated in Liver Cirrhosis (ZEAL Study)

Clinical trial NCT05516498 · TERMINATED

Trial details

NCT number: NCT05516498
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Liver Cirrhosis

Start date: 2022-10-31
Primary completion: 2025-05-22
Enrollment: 205

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.